| MOPEA09 | Patient-derived envelope sequences are differentially resistant to SERINC5-mediated restriction of HIV-1 infectivity | Poster exhibition | Host immune responses, vaccines and immunotherapies |
| EPC0303 | Past-year transactional sex associated with HIV and STIs among MSM in the U.S.: findings from the American Men’s Internet Survey, 2017-2021 | E-poster | Epidemiology of HIV |
| EPB0216 | Participant-reported outcomes with long-acting lenacapavir-based regimens among heavily treatment-experienced people living with HIV in the CAPELLA clinical trial | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPD0531 | Participant perspectives on incentives for TB preventative therapy adherence and reduced alcohol use: a qualitative study | E-poster | Social science theories, concepts and methods |
| EPC0395 | Parrying the pitfalls of PrEP: preventing premature PrEP discontinuation and STIs among men who have sex with men | E-poster | HIV prevention research |
| EPD0695 | Parent/guardians knowledge, attitudes and perceptions on long acting injectable cabotegravir (CAB LA) for HIV prevention and study participation in HPTN 084-01 study: tales from Mu-JHU, Kampala site | E-poster | Key populations and other vulnerable populations: Behavioural, social and cultural issues and contexts |
| EPA0054 | P400/Tip60 chromatin remodeling complex in HIV transcription and latency establishment | E-poster | Understanding and targeting persistent HIV reservoirs |
| TUPEE02 | Out-of-pocket payments in accessing antiretroviral treatment among People Living with HIV (PLHIV) in Indonesia | Poster exhibition | Global and national financing, economic evaluation and sustainability |
| EPB0239 | Outcomes of children living with HIV transitioned to Dolutegravir based antiretroviral therapy regimens in Midlands and Manicaland Provinces of Zimbabwe, 2022 | E-poster | Antiretroviral therapies and clinical issues in infants, children and adolescents |
| EPB0259 | Outcomes from the Transitioning children to Optimal Regimens of Paediatric Dolutegravir (TORPEDO) study at 6 months in Benin, Nigeria, and Uganda | E-poster | Antiretroviral therapies and clinical issues in infants, children and adolescents |